HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Radium-223: the newest option in metastatic castration-resistant prostate cancer.

AuthorsOliver Sartor
JournalClinical advances in hematology & oncology : H&O (Clin Adv Hematol Oncol) Vol. 11 Issue 12 Pg. 801-3 (Dec 2013) ISSN: 1543-0790 [Print] United States
PMID24893286 (Publication Type: Interview)
Chemical References
  • Antineoplastic Agents
  • Radioisotopes
  • Radiopharmaceuticals
  • radium Ra 223 dichloride
  • Radium
Topics
  • Antineoplastic Agents (therapeutic use)
  • Castration
  • Humans
  • Male
  • Neoplasm Metastasis
  • Portraits as Topic
  • Prostatic Neoplasms (drug therapy, pathology)
  • Radioisotopes (therapeutic use)
  • Radiopharmaceuticals (therapeutic use)
  • Radium (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: